Eagle Pharmaceuticals
EGRX
#10440
Rank
โ‚น0.41 B
Marketcap
โ‚น32.07
Share price
0.00%
Change (1 day)
-53.68%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: โ‚น0.41 Billion

As of February 2026 Eagle Pharmaceuticals has a market cap of โ‚น0.41 Billion. This makes Eagle Pharmaceuticals the world's 10440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น0.41 B-20.6%
2025โ‚น0.52 B-14.38%
2024โ‚น0.61 B-89.19%
2023โ‚น5.65 B-82.04%
2022โ‚น31.48 B-35.68%
2021โ‚น48.94 B10.29%
2020โ‚น44.37 B-24%
2019โ‚น58.39 B48.98%
2018โ‚น39.19 B-22.98%
2017โ‚น50.89 B-39%
2016โ‚น83.43 B-9.44%
2015โ‚น92.13 B568.2%
2014โ‚น13.78 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
โ‚น0.41 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น50.174 T 12,071,930.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น26.143 T 6,290,134.49%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
โ‚น85.204 T 20,500,064.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น16.870 T 4,059,004.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น10.270 T 2,470,877.76%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น9.556 T 2,299,288.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚น3.583 T 861,997.57%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel